ImmuCell Corp (NASDAQ: ICCC) stock closed at $4.12 on 11/29/24 after a major increase of 10.8%. Trading volume in this advance was normal. The stock has risen 14.4% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
ImmuCell has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. ImmuCell has a poor Appreciation Score of 24 and a poor Power Rating of 16, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment